(19)
(11) EP 3 397 639 A1

(12)

(43) Date of publication:
07.11.2018 Bulletin 2018/45

(21) Application number: 16826561.9

(22) Date of filing: 22.12.2016
(51) International Patent Classification (IPC): 
C07D 471/16(2006.01)
A61P 31/18(2006.01)
A61K 31/5025(2006.01)
(86) International application number:
PCT/US2016/068173
(87) International publication number:
WO 2017/116928 (06.07.2017 Gazette 2017/27)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 31.12.2015 WO PCT/CN2015/100106

(71) Applicant: Merck Sharp & Dohme Corp.
Rahway, NJ 07065-0907 (US)

(72) Inventors:
  • YU, Tao
    Kenilworth New Jersey 07033 (US)
  • WADDELL, Sherman, T.
    Westfield New Jersey 07090 (US)
  • GRAHAM, Thomas, H.
    Boston Massachusetts 02115-5727 (US)
  • ZHANG, Yonglian
    Kenilworth New Jersey 07033 (US)
  • MCCAULEY, John, A.
    West Point Pennsylvania 19486 (US)
  • STAMFORD, Andrew, W.
    Chatham Township New Jersey 07928 (US)
  • CAI, Jiaqiang
    Shanghai 200131 (CN)
  • QI, Zhiqi
    Shanghai 200131 (CN)

(74) Representative: Jaap, David Robert 
MSD Hertford Road
Hoddesdon, Herts EN11 9BU
Hoddesdon, Herts EN11 9BU (GB)

   


(54) FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS